Improve balance during dual tasking

Trial ID
NCT06615115
Official Title
Effects of an External and Combined Focus of Attention-Instructed Exercise Program on Postural Stability and Dual-Task Walking in Parkinson's Disease: A Randomized, Assessor-Blinded, Controlled Trial
Goal
Improve balance during dual tasking
Phase
NA
Status
RECRUITING
Sponsor
Bahçeşehir University
Study Type
INTERVENTIONAL
Enrollment
48 participants
Conditions
Parkinson Disease, Cognitive Deficit in Attention, Feedback, Psychological, Gait, Festinating
Interventions
Exercise

Summary For Families

It aims to improve postural stability and walking while multitasking, the kinds of balance and dual-task problems that increase fall risk and cause festinating gait. The program uses guided exercises that teach an external and combined focus of attention, meaning people are cued to focus on movement outcomes or external targets instead of their body, which encourages more automatic motor control and steadier balance and gait under dual-task conditions. The trial is enrolling people aged 50 to 70 with mild to moderate Parkinson's, Hoehn and Yahr stage II or III, who walk independently but have balance issues, score 21,56 on the Berg Balance Scale and 24,30 on the MMSE, are in their medication-on period, and do not have freezing of gait, deep brain stimulators, dyskinesia, major neurological or sensory problems, or serious medical conditions.

Locations

  • Atafiz Tıp Merkezi, Istanbul, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying Exercise. It aims to improve postural stability and walking while multitasking, the kinds of balance and dual-task problems that increase fall risk and cause festinating gait. The program uses guided exercises that teach an external and combined focus of attention, meaning people are cued to focus on movement outcomes or external targets instead of their body, which encourages more automatic motor control and steadier balance and gait under dual-task conditions. The trial is enrolling people aged 50 to 70 with mild to moderate Parkinson's, Hoehn and Yahr stage II or III, who walk independently but have balance issues, score 21,56 on the Berg Balance Scale and 24,30 on the MMSE, are in their medication-on period, and do not have freezing of gait, deep brain stimulators, dyskinesia, major neurological or sensory problems, or serious medical conditions.
Who can participate?
Participants must be between 50 Years and 70 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 4 months.
Will I get the real drug or a placebo?
It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
How often will I need to visit the study site?
Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Will travel or parking be reimbursed?
Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.

Related Reading

View on ClinicalTrials.gov